<DOC>
	<DOCNO>NCT00004328</DOCNO>
	<brief_summary>OBJECTIVES : I . Establish sodium potassium intake maintain normovolemic state patient pseudohypoaldosteronism . II . Determine effect extracellular fluid volume serum potassium manipulation exercise tolerance , cardiac function , endurance . III . Investigate pharmacologic method limit excretion sodium urine sweat .</brief_summary>
	<brief_title>Phase II Study Pathophysiology Treatment With Enalapril Polystyrene Sulfonate Pseudohypoaldosteronism , Type I</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Sodium potassium intake result normalization serum electrolytes marker extracellular volume determine baseline . A trial diet prescribe , adjustment make achieve steady state normal serum electrolyte . Exercise tolerance muscle function evaluate steady state . Sodium potassium sequentially manipulate diet , enalapril , polystyrene sulfonate . Exercise tolerance evaluate diet period . A treatment plan maintain electrolyte balance develop . The patient follow monthly 3 6 month , every 3 month 3 year .</detailed_description>
	<mesh_term>Pseudohypoaldosteronism</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Pseudohypoaldosteronism</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2000</verification_date>
	<keyword>endocrine disorder</keyword>
	<keyword>pseudohypoaldosteronism</keyword>
	<keyword>rare disease</keyword>
</DOC>